{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06374186",
            "orgStudyIdInfo": {
                "id": "2095072"
            },
            "secondaryIdInfos": [
                {
                    "id": "2095072",
                    "type": "OTHER",
                    "domain": "UMKC IRB"
                }
            ],
            "organization": {
                "fullName": "University of Missouri, Kansas City",
                "class": "OTHER"
            },
            "briefTitle": "Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City",
            "officialTitle": "COntinuous Glucose Monitoring, Contingency Management, and Motivational InTerviewing for Patients With TypE 2 Diabetes in Kansas City",
            "acronym": "COMMITTED2-KC",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "continuous-glucose-monitoring-contingency-management-and-motivational-interviewing-for-patients-with-type-diabetes-in-kansas-city"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-04",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-05-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-12-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-04-08",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-04-15",
            "studyFirstSubmitQcDate": "2024-04-15",
            "studyFirstPostDateStruct": {
                "date": "2024-04-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-04-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-18",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "University of Missouri, Kansas City",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study is evaluating a behavioral treatment program that uses diabetes coaching and financial rewards in addition to continuous glucose monitoring to improve diabetes management in adult patients with type 2 diabetes. This study will evaluate if this behavioral treatment program increases individual adherence to a diabetes treatment plan and improves blood sugar management.",
            "detailedDescription": "A randomized parallel-group pilot study of a combination intervention using Motivational Interviewing (MI) and Contingency Management (CM) for patients with T2DM. Individuals will be randomized in a 1:1 ratio to the intervention group or the control group. Randomization will be blocked and stratified by long-acting insulin and GLP1 medication use. All participants will be given a Continuous Glucose Monitor (CGM) to assess real-time blood sugar levels and establish CM rewards for those assigned to the treatment group."
        },
        "conditionsModule": {
            "conditions": [
                "Type 2 Diabetes"
            ],
            "keywords": [
                "Type 2 Diabetes",
                "Glucose",
                "contingency management",
                "motivational interviewing"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "A randomized parallel-group pilot study of a combination intervention using Motivational Interviewing (MI) and Contingency Management (CM) for patients with T2DM.",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "maskingDescription": "Because this is a behavioral intervention, participant blinding is not possible. Randomization will occur after baseline assessment and participants will be instructed to not tell their provider their assigned condition.",
                    "whoMasked": [
                        "CARE_PROVIDER"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 40,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Behavioral Intervention with financial rewards and coaching",
                    "type": "EXPERIMENTAL",
                    "description": "Individuals in the treatment group will receive financial rewards (contingency management) and diabetes coaching (motivational interviewing) in addition to wearing a continuous glucose monitor while receiving their usual diabetes treatment.",
                    "interventionNames": [
                        "Behavioral: Behavioral Intervention with financial rewards and coaching"
                    ]
                },
                {
                    "label": "Control",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Individuals in the control group will not receive any interventions and will only wear a continuous glucose monitor while receiving their usual diabetes treatment.",
                    "interventionNames": [
                        "Behavioral: Control"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "BEHAVIORAL",
                    "name": "Behavioral Intervention with financial rewards and coaching",
                    "description": "Participants will receive variable financial incentives based on their engagement with the continuous glucose monitor and meeting diabetes treatment goals. In addition, they will participate in three motivational interviewing sessions focused on their diabetes management. Participants will continue to receive their diabetes treatment as usual.",
                    "armGroupLabels": [
                        "Behavioral Intervention with financial rewards and coaching"
                    ],
                    "otherNames": [
                        "Contingency management and motivational interviewing"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Control",
                    "description": "Participants will only receive a continuous glucose monitor, which they may engage with as desired and no further intervention. Participants in the control group will continue to receive their diabetes treatment as usual.",
                    "armGroupLabels": [
                        "Control"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Time in target blood glucose range per CGM",
                    "description": "Percent time with blood glucose between 70 to 180 mg/dL",
                    "timeFrame": "baseline to 14 weeks"
                },
                {
                    "measure": "Hemoglobin A1C",
                    "description": "laboratory value",
                    "timeFrame": "baseline to 12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Diabetes Quality of Life Brief Inventory",
                    "description": "self-report questionnaire",
                    "timeFrame": "baseline to 12 weeks"
                },
                {
                    "measure": "Diabetes Distress Scale",
                    "description": "self-report questionnaire",
                    "timeFrame": "Baseline to 12 weeks"
                },
                {
                    "measure": "PROMIS Medication Adherence Scale",
                    "description": "self-report questionnaire",
                    "timeFrame": "Baseline to 12 weeks"
                },
                {
                    "measure": "Perceived Dietary Adherence Questionnaire",
                    "description": "self-report questionnaire",
                    "timeFrame": "Baseline to 12 weeks"
                },
                {
                    "measure": "Motivation and Confidence Ruler",
                    "description": "self-report questionnaire",
                    "timeFrame": "Baseline to 12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Diagnosed with type 2 diabetes\n2. Age 18 to 65\n3. Hemoglobin A1c (blood draw or point-of-care) test available within the last 3 months\n4. Most recent hemoglobin A1c result between 8.0 and 11.0\n5. Currently receiving treatment for diabetes by a licensed healthcare provider.\n6. Reliable access to a personal smart phone that is compatible with CGM\n7. English speaking\n\nExclusion Criteria:\n\n1. Type 1 diabetes\n2. Secondary type 2 diabetes (diagnosis secondary to other medical conditions such as pancreatitis, Cystic Fibrosis, or Cushing disease)\n3. Prescribed short-acting (mealtime) insulin as part of diabetes treatment plan\n4. Known or acknowledged active substance use disorder or that would interfere or negatively impact participation in the study\n5. Diagnosis of a medical/psychiatric condition that would prevent participation in the study (e.g., Intellectual Disability, Alzheimer's disease, Traumatic Brain Injury, Schizophrenia)",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Carrie Kriz, MS",
                    "role": "CONTACT",
                    "phone": "816-512-7473",
                    "email": "mckinleycr@umkc.edu"
                },
                {
                    "name": "Jared Bruce, PhD",
                    "role": "CONTACT",
                    "phone": "816-235-1068",
                    "email": "brucejm@umkc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Jared Bruce, PhD",
                    "affiliation": "University of Missouri, Kansas City",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Missouri - Kansas City School of Medicine",
                    "city": "Kansas City",
                    "state": "Missouri",
                    "zip": "64108",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Carrie R Kriz",
                            "role": "CONTACT",
                            "phone": "816-512-7473",
                            "email": "mckinleycr@umkc.edu"
                        },
                        {
                            "name": "Jared M Bruce, PhD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.09973,
                        "lon": -94.57857
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000003924",
                    "term": "Diabetes Mellitus, Type 2"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M7119",
                    "name": "Diabetes Mellitus, Type 2",
                    "asFound": "Type 2 Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}